Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability, and PK of Methosulide in Healthy Adults
NCT02374684Phase 1Completed
- Sponsor
- Hubei Bio-Pharmaceutical Industrial Technological Institute
- Start
- Feb 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pain and inflammation comparing Methosulide with Placebo (2 arms). Primary endpoint: Frequency of drug-related clinical adverse events. Started Feb 2015; status: completed.
02
Drugs
methosulide
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT02374684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374684.